Orthotopic liver transplantation is the accepted treatment for endstage liver disease. In the US alone, more than 3 000 patients receive liver transplants yearly distributed through more than 100 liver transplant programmes.
INTRODUCTION
Orthotopic liver transplantation (OLT) has become the standard surgical procedure and fully accepted treatment for patients with endstage liver disease and fulminant hepatic failure.
According to United Network for Organ Sharing (UNOS) data, in the US, 3 443 patients received liver transplants in 1993'. At the University of Nebraska Medical Center (UNMC), by April of 1996, 1167 liver transplant procedures had been performed since the initiation of our liver transplantation program in 1985. The vast majority of the patients are doing well after the transplant with a 5-year survival rate of 75%; however, a group of patients experience neurologic complications. Among them, seizures are the most frequent. In the post-transplant setting, neurologists are consulted most commonly for evaluation of mental 'status changes and for diagnosis and treatment of seizures. In this review article, frequency and time of occurrence of seizures in OLT patients, types of seizures, their aetiology, diagnostic assessment and treatment are discussed.
FREQUENCY AND TIME OF OCCURRENCE
Seizures are a common occurrence in the OLT population.
In clinical consecutive series, the frequency of seizures varies between 2.8 and 42% and in autopsy series the frequency varies between 8.1 and 35% (Table 1) 2-". Seizures tend to occur in a bimodal distribution within the first 7 days after transplantation and between 5 and 16 weeks after transplantation ( Fig. 1) 12. Patients who are undergoing retransplantation are also at high risk of developing seizures. In a series of 185 patients who had two or more OLTs, seizures occurred in 33%'3.
TYPES OF SEIZURES
Generalized seizures are the most common type of seizure observed after OLT. Clinically, however, it is often difficult to determine if a given seizure was generalized from its onset or whether it was secondarily generalized, as the focal onset may have been brief and lacked clinical detection. For this reason, there is a tendency to underestimate the prevalence of seizures of focal origin and this also applies to the transplant population. Summarizing a number of clinical and autopsy series; generalized seizures were seen in 39 patients, focal seizures in 10 patients, status epilepticus in five patients, and myoclonic seizures in three patients (Table 1 )"". Sex distribution was discussed in only three articles: (M:F = 3:1)", (4:0)", and (3:4)6. 52 ( 13) 83 (18) 85 (30) 35 (10) 83 (7) 27 (8) 37 (3) 40 (8) 143 ( (Constructed from data in Table 1) myoclonus'4~'5. Multichannel surface EMG studies combined with EEG may delineate the cause in such cases. We have observed two patients with cyclosporine toxicity who were obtunded and exhibited coarse tremors in the upper extremities.
Their combined EEG and EMG tracings confirmed a non-epileptic nature of their movement disorder.
AETIOLOGY
The aetiology of seizures after OLT is usually multifactorial.
However, in many cases a single aetiology may be present. While seizures in the OLT recipient may often occur due to focal brain injury, metabolic abnormalities may predispose these patients to seizures as suggested in earlier reports12. The most commonly identified underlying causes for seizures in OLT recipients include metabolic derangements, drugs (especially cyclosporine and OKT3), hypoxicischemic injury, cerebral structural lesions, and infection3-5'7-9.ll.12.'".
Electrolyte disturbances
A variety of electrolyte disturbances have been encountered in liver transplant patients. However, those most frequently responsible for seizures include hypomagnesemia, hypocalcemia, and hyponatremia3-5*8*9V"V12*16*17. Seizures occurred in 20% of U.C.L.A. patients following liver transplantation, usually in the setting of hypomagnesemia and high cyclosporin A levels. Cyclosporin A is known to cause magnesium wasting, and magnesium levels must be monitored17. An electrolyte abnormality may occur alone, in combination with other metabolic derangements, or accompany other potential aetiologies for seizures.
Medication effects
After OLT, patients are treated with immunosuppressant medications. Those which have been identified as possible causes of seizures include cyclosporine, OKT3 and FK 506. Nephrotoxicity, neurotoxicity, and impaired glucose metabolism are commonly associated with the use of either FK 506 (tacrolimus) or. cyclosporine. The incidence of adverse neurologic events including tremor and paraesthesia have been reported to be significantly higher with FK 506 compared to cysclosporine, while severe adverse neurologic events such as convulsions are relatively rare with the use of either of these two agents . 18V19 In this clinical setting, dose reduction or discontinuation of the offending medication usually leads to complete recovery20*2'. There are a number of experimental immunosuppressive agents under study in liver transplantation including rapamycin, RS61443 (mycophenolic acid mofetyl), deoxyspergualin, brequinar, prostaglandins, thalidomide, ursodeoxycholic acid, monoclonal antibodies, antithymocyte globulin, anti-CD45 monoclonal antibody, antibodies to lymphocyte antigens, anticytokine antibodies and antiadhesion molecules .
I4 Presently, their relative potential to induce seizures is not known. High dose steroids for treatment of graft rejection have also been implicated in seizures.
Following OLT, patients may develop pulmonary complications requiring treatment with theophylline.
Theophylline related seizures usually occur with elevated or toxic blood levels; however, it may contribute to seizures in patients with other potential causes such as electrolyte disturbances or infection. As patients with liver disease exhibit decreased demethylation of theophylline, seizures may occur with therapeutic levels of this drug, especially if the patient is also receiving quinolone derivatives, such as ciprofloxacin and norfloxacin22-24. In patients with infection requiring antibiotics, caution should be exercised especially with mezlocillin and imipenem which are also known to precipitate seizures22.
Cerebral structural lesions
A variety of cerebral structural lesions which have been reported to occur more commonly in OLT patients include intracerebral haemorrhage, subarachnoid haemorrhage, cerebral infarction, and brain abscess, all of which may contribute to seizures5s8,9. In the UNMC-Mayo Clinic joint study of patients with neurologic abnormalities after OLTz5, there were 11 patients who had seizures and also underwent autopsy. Eight of them had a structural abnormality.
In another autopsy series by Martinez et a15, 30 patients had seizures following OLT. Eight were found to have subarachnoid haemorrhage, intracerebral haemorrhage, or brain haerniation. Overwhelming infection in the liver transplant recipient may predispose intracerebral haemorrhagez6.
Infection
The most common are fungal and viral infections of the central nervous system (CNS). Aspergillosis is the most common fungal infection of the CNS in the OLT recipient. Cryptococcal leptomeningitis5, listeria meningitis', and a mycobacteria tuberculosis abscess2' have also been reported to cause seizures in OLT recipients. Ebstein-Barr virus infection can cause a posttransplant lymphoproliferative disease. The clinical presentation includes unexplained fever, malaise, lymphadenopathy, gastrointestinal abnormalities including gut perforation, and central nervous system dysfunction including mental status changes, focal neurologic signs, and seizures2829.
Less common causes
Hypoxic-ischemic encephalopathy may result from abnormalities in blood pressure control, respiratory arrest and graft rejection and give rise to seizures. Pre-existing neurologic conditions including prior epilepsy and the inadvertent discontinuation of antiepileptic medication or subtherapeutic antiepileptic blood levels are also potential causes for seizures after OLT. The effect of OLT on seizure control in patients with a prior history of epilepsy is presently not known. OLT has become a more widely utilized procedure in patients with Laermec's cirrhosis. Recidivism rates up to 50% have been reported following transplantation3' and these patients are at risk for alcohol withdrawal and alcohol-related seizures.
DIAGNOSTIC ASSESSMENT
A variety of diagnostic tests must be implemented due to the many potential causes of seizures following OLT. The most frequently utilized are EEG "Zig' (Figs 2-5) and CT of the head. According to Moreno et al, CT was used 85.7% and EEG 42.8% of the time in the evaluation of OLT patients with neurologic complications". The utilization of specific tests will of course depend on the patient's individual clinical underlying condition. The CT scan has the advantage of being readily available and can provide useful clinical information such as the presence of intracranial haemorrhage; however, MRI has superior brain tissue resolution making it a more sensitive study. However, MRI is more difficult to obtain in the critically ill patient, particularly in the intubated patient and patients who are unable to remain still. Therefore, a CT scan of the head remains the first diagnostic option.
In patients with altered mental states, the EEG can help differentiate an encephalopathic state from non-convulsive status epilepticus, and tremors from true seizure activity (Fig. 5) . EEG is also helpful in prognosis. In our series2', epileptiform activity on the EEGs of patients who had undergone OLT was associated with a variety of structural abnormalities, including intracranial haemorrhage, cerebral oedema, pontine and extrapontine myelinolysis, and cortical infarctions leading to a complicated clinical course and a shortened survival.
The other diagnostic tests utilized in the evaluation of the OLT patient with seizures are presented in Table 2 . In those patients with pre-existing seizure disorders, it is especially important to measure blood levels of administered anticonvulsants.
MANAGEMENT
Treatment of the OLT patient who has seizures is challenging since there are numerous aetiologies in this patient population.
Treatment of the underlying cause of the seizures should always be undertaken together with the administration of anticonvulsant medication. Special attention should be given to the correction of electrolyte imbalances, treatment of infection, and intra- cranial haemorrhage. Neurosurgical management may be necessary in selected cases such as cerebral abscess or subdural haematoma.
In our experience, the most useful anticonvulsant in patients who have undergone OLT is phenytoin. Although the recommended loading dose is lo-20 mg/kg body weight, we find doses in the 18-20 mg/kg range necessary to achieve high therapeutic levels. Both total and free phenytoin levels should be measured, because patients who have undergone OLT may have hypoalbuminemia and decreased protein binding of phenytoin. This can result in a toxic free phenytoin level when the total level is in the usual therapeutic range and a therapeutic free phenytoin level may be achieved when the total level is in the subtherapeutic range. This is especially likely to occur if the blood urea nitrogen (BUN) and creatinine levels are increased33.
Phenobarbital is also a frequently used anticonvulsant medication; however, because phenobarbital can cause excessive sedation, hypotension during intravenous administration and respiratory suppression, phenytoin remains the drug of choice. The intravenous loading dose of Carbamazepine can be utilized, but due to the lack of an intravenous preparation and the difficulty in administering loading doses, it is rarely used unless the patient has a history of epilepsy and was on carbamazepine preoperatively. For the same reason, valproic acid is not frequently used and in addition, it possesses greater hepatotoxicity.
It should be noted that carbamazepine, phenobarbital, phenytoin and primidone may decrease cyclosporine blood levels by induction of P-450111A (cyclosporine oxidase)22-2J. This process may take up to 10 days to occur. Ergotamine derivatives which are used to treat vascular headaches may lead to increased cyclosporine blood levels through the inhibition of cyclosporine oxidase**.
Felbamate, gabapentin and lomotrigine are newly released anticonvulsants, the latter two for add-on therapy. There are no published reports on the use of these medications in the liver 
